Paul de Bakker

Paul I. Wen de Bakker (born 1973) is a Dutch bioinformatician who specializes in computational biology and genetic epidemiology. He has been Senior Director of Computational Genomics at Vertex Pharmaceuticals since 2015. He previously worked at Harvard Medical School from 2007 to 2012, and served as Professor of Genetic Epidemiology and Bioinformatics at the University of Utrecht from 2012 to 2015.[3] He is known for his research on the genetics of innate resistance to HIV.[4][5][6]

Paul de Bakker
Born	Paul I. Wen de Bakker 24 August 1973 [1] Rotterdam
Nationality	Netherlands
Education	University of Bristol Utrecht University University of Cambridge
Known for	Computational genomics
Scientific career
Fields	Computational biology Genetic epidemiology
Institutions	Harvard Medical School (2007–2012) University of Utrecht (2012–2015) Vertex Pharmaceuticals (2015–present)
Thesis	Ab initio sampling of polypeptide conformations and the prediction of protein structure (2003)
Doctoral advisor	Tom Blundell[2]

References

1. ProfessorProf.dr. P.I.W. de Bakker (1973 - ) at the Catalogus Professorum of the University of Utrecht
2. "Paul de Bakker". Paul de Bakker Lab. Retrieved 2018-12-31.
3. "News". McCammon Group. Retrieved 2018-12-31.
4. Heisler, Gregory (2009-01-15). "The Rare Few". Proto Magazine. Retrieved 2018-12-31.
5. Finkel, Elizabeth (2012). The Genome Generation. Melbourne Univ. Publishing. pp. 141–3. ISBN 9780522856477.
6. Davis, Daniel Michael (2014). The Compatibility Gene: How Our Bodies Fight Disease, Attract Others, and Define Our Selves. Oxford University Press. p. 92. ISBN 9780199316410.

External links

• Paul de Bakker publications indexed by Google Scholar